Avid Amyvid Could Be Approved If Training Improves, Advisory Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Peripheral and Central Nervous System Drugs Advisory Committee demands a second voting question to say the data support approval of the amyloid plaque diagnostic, but not until more consistent interpretation methods are developed.